Quantitative relationship between oral temperature and severity of illness following inoculation with candidate attenuated dengue virus vaccines
- PMID: 7893886
- DOI: 10.1093/clinids/19.5.948
Quantitative relationship between oral temperature and severity of illness following inoculation with candidate attenuated dengue virus vaccines
Abstract
The relationship between oral temperature and other parameters of illness was examined in 51 adult volunteers who were inoculated experimentally with partially attenuated candidate dengue virus vaccines. In subjects who developed clinical illness, the peak illness temperature, mean illness temperature, and peak 6:00 A.M. illness temperature all correlated positively with the total number of signs and symptoms other than fever and with a fall in the white blood cell count (the latter was the only laboratory abnormality significantly associated with clinical illness [P = .02]). Of these factors, the peak 6:00 A.M. oral temperature exhibited the strongest correlations with the two parameters used to estimate severity of illness (rxy = .58 and P < .01 for signs and symptoms; rxy = .37 and P = .01 for fall in white blood cell count).
Similar articles
-
A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans.J Infect Dis. 1994 Dec;170(6):1448-55. doi: 10.1093/infdis/170.6.1448. J Infect Dis. 1994. PMID: 7995984 Clinical Trial.
-
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.J Virol. 2000 Jun;74(12):5477-85. doi: 10.1128/jvi.74.12.5477-5485.2000. J Virol. 2000. PMID: 10823852 Free PMC article.
-
Dengue-2 vaccine: virological, immunological, and clinical responses of six yellow fever-immune recipients.Infect Immun. 1981 Feb;31(2):698-703. doi: 10.1128/iai.31.2.698-703.1981. Infect Immun. 1981. PMID: 7216469 Free PMC article.
-
The future of dengue vaccines.Lancet. 2002 Oct 19;360(9341):1243-5. doi: 10.1016/S0140-6736(02)11276-1. Lancet. 2002. PMID: 12401270 Review. No abstract available.
-
Development of new vaccines against dengue fever and Japanese encephalitis.Intervirology. 2001;44(2-3):176-97. doi: 10.1159/000050045. Intervirology. 2001. PMID: 11509879 Review.
Cited by
-
Dr William Coley and tumour regression: a place in history or in the future.Postgrad Med J. 2003 Dec;79(938):672-80. Postgrad Med J. 2003. PMID: 14707241 Free PMC article.
-
A phase II, randomized, safety and immunogenicity study of a re-derived, live-attenuated dengue virus vaccine in healthy adults.Am J Trop Med Hyg. 2013 Jan;88(1):73-88. doi: 10.4269/ajtmh.2012.12-0361. Epub 2012 Dec 3. Am J Trop Med Hyg. 2013. PMID: 23208878 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical